Jonas S Heitmann

11PUBLICATIONS
50CO-AUTHORS
Tumour immunologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 18, 2023
TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification.

Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer

|Oct 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.

Annika Nelde, Heiko Schuster, Jonas S Heitmann

|Aug 18, 2023
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.

Jonas S Heitmann, Claudia Tandler, Maddalena Marconato

|May 13, 2022
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro.

Joseph Kauer, Melanie Märklin, Martin Pflügler

|Aug 23, 2021
SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function.

Fabian Brunk, Andreas Moritz, Annika Nelde

|Mar 16, 2021
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals.

Tatjana Bilich, Annika Nelde, Jonas S Heitmann

Pageof 2

Frequent Collaborators

7 joint publications

Helmut R Salih

6 joint publications

Melanie Märklin

5 joint publications

Juliane Walz

5 joint publications

Annika Nelde